Comparative Study of Loxoprofen Sodium Transdermal Patch and Loxonin® Tablets for the Treatment of Acute Trauma
Status:
Completed
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
This study evaluates the non-inferiority of the new transdermal patch dosage form containing
loxoprofen sodium (100 mg - Daiichi-Sankyo) in comparison with oral Loxonin® (60 mg tablet -
Daiichi-Sankyo) for the treatment of acute traumatic injuries.